Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer

Clinical trial NCT01580397 · COMPLETED

Trial details

NCT number: NCT01580397
Sponsor: ImmunityBio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma

Start date: 2012-05-16
Primary completion: 2013-05-13
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.